Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-001529

ChemoCentryx, Inc. · CCXI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Susan M Kanaya
Officer — EVP, CFO and Sec.
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 7:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 1, 2018M20,000$0.00A43,851D
Common StockJan 1, 2018M13,333$0.00A57,184D
Common StockF3Jan 1, 2018F19,049$5.95D38,135D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5—Jan 1, 2018M20,000D——Common Stock20,00020,000D
Restricted Stock UnitsF4,F6—Jan 1, 2018M13,333D——Common Stock13,33326,667D

Explanation of responses